Tvardi Therapeutics, Inc. (NASDAQ:TVRD) showed up in the 13F filings of 64 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Slate Path Capital LP | 31 Dec, 2025 | 704,118 | 0 | 0.00% | $3,027,707.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 424,821 | 5,654 | 1.35% | $1,826,730.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 391,000 | 61,086 | 18.52% | $1,681,300.00 |
| American Financial Group Inc | 31 Dec, 2025 | 223,659 | 223,659 | 0.00% | $961,734.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 157,133 | 9,214 | 6.23% | $675,826.00 |
| State Street Corp | 31 Dec, 2025 | 115,501 | 52,637 | 83.73% | $496,654.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 104,500 | 74,325 | 246.31% | $449,350.00 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 31 Dec, 2025 | 101,034 | 78,668 | 351.73% | $434,446.00 |
| Morgan Stanley | 31 Dec, 2025 | 84,466 | 80,680 | 2,131.01% | $363,205.00 |
| Duncan Williams Asset Management, LLC | 31 Dec, 2025 | 80,771 | 80,771 | 0.00% | $311,776.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 66,262 | 42,233 | 175.76% | $284,926.00 |
| Squarepoint Ops LLC | 31 Dec, 2025 | 51,783 | 43,619 | 534.28% | $222,667.00 |
| Northern Trust Corp | 31 Dec, 2025 | 47,882 | 5,499 | 12.97% | $205,893.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 47,444 | 47,444 | 0.00% | $204,010.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 43,225 | -43,225 | -50.00% | $185,868.00 |
| UBS Group AG | 31 Dec, 2025 | 35,555 | -12,924 | -26.66% | $152,887.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 25,382 | -5,342 | -17.39% | $109,142.00 |
| Quadrature Capital Ltd | 31 Dec, 2025 | 20,964 | 20,964 | 0.00% | $90,145.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 18,146 | 8,480 | 87.73% | $78,027.00 |
| Russell Investments Group, Ltd. | 31 Dec, 2025 | 15,966 | 14,866 | 1,351.45% | $68,654.00 |